Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16,572.58% | -804.13% | -186.15% | -992.97% | -96.61% |
| Total Depreciation and Amortization | -8.63% | 1.04% | 13.51% | 12.08% | 8.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,295.18% | 580.15% | -9.74% | 8.62% | -95.90% |
| Change in Net Operating Assets | 37.85% | 96.37% | -54.28% | -0.62% | 40.56% |
| Cash from Operations | -100.36% | 111.70% | -81.96% | -71.96% | -81.99% |
| Capital Expenditure | 41.31% | 27.32% | 27.29% | 24.68% | -7.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -151.76% | -993.10% | -14.96% | 87.86% | -35.51% |
| Cash from Investing | -79.12% | -279.38% | 10.82% | 70.11% | -25.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -97.22% | -100.00% |
| Repurchase of Common Stock | -122.37% | -118.23% | -110.05% | 55.74% | 56.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 12.82% | 13.27% | 55.78% | 72.73% | 98.96% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -75.62% | -72.76% | -53.66% | 62.77% | 97.09% |
| Foreign Exchange rate Adjustments | -- | 0.00% | -87.50% | -91.49% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.78% | -371.12% | -250.85% | 53.73% | -717.41% |